Holen Sie sich die Stockscreener-App
73.77
0.05%
0.04
Handel nachbörslich:
73.77
Schlusskurs vom Vortag:
$73.73
Offen:
$73.6
24-Stunden-Volumen:
1.56M
Relative Volume:
0.96
Marktkapitalisierung:
$9.17B
Einnahmen:
$12.50B
Nettoeinkommen (Verlust:
$314.00M
KGV:
21.57
EPS:
3.42
Netto-Cashflow:
$421.00M
1W Leistung:
+10.87%
1M Leistung:
+3.05%
6M Leistung:
+0.71%
1J Leistung:
+7.04%
1-Tages-Spanne:
$71.98
$73.97
1-Wochen-Bereich:
$66.17
$76.84
52-Wochen-Spanne:
$63.67
$82.63
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Vergleichen Sie HSIC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| HSIC | 73.77 | 9.17B | 12.50B | 314.00M | 421.00M | 3.42 |
| MCK | 628.04 | 81.25B | 330.19B | 2.54B | 4.31B | 25.31 |
| COR | 245.61 | 47.76B | 293.96B | 1.51B | 3.00B | 8.53 |
| CAH | 123.40 | 29.74B | 224.34B | 1.26B | 1.08B | 0.61 |
| PDCO | 20.28 | 1.76B | 6.57B | 185.93M | -857.00M | 2.19 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Henry Schein to acquire medical supplier Acentus - MedTech Dive
Thompson Siegel & Walmsley LLC Buys 274,756 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein to Participate in Investor Conferences in December - Business Wire
Henry Schein's COO Michael Ettinger sells $918,000 in stock By Investing.com - Investing.com South Africa
Henry Schein shake-up sought by investment fund that calls for cost cuts, higher profits, new board - Newsday
Henry Schein: Another Day, Another Purchase (NASDAQ:HSIC) - Seeking Alpha
Henry Schein's COO Michael Ettinger sells $918,000 in stock - Investing.com
$35 million Tampa medical supply company acquired - Business Observer
Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products - BioSpace
Henry Schein to Buy Homecare Medical Product Supplier Acentus - MPO-mag
Nuance Investments LLC Has $166.07 Million Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Peering Into Henry Schein's Recent Short Interest - Benzinga
Henry Schein to acquire Acentus - MSN
Henry Schein to acquire Acentus, terms not disclosed - TipRanks
Henry Schein Expands Medical Supply Empire with $35M Acentus Acquisition | HSIC Stock News - StockTitan
Exclusive-Activist investor Ananym Capital pushes for changes at Henry Schein, sources say - MSN
Henry Schein extends gain on report of activist stake, push for board changes - MSN
Henry Schein shares retain Overweight rating as Piper Sandler comments on Ananym Capital proposals - Investing.com
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Ananym Capital Management Pushes for Changes at Henry Schein - Marketscreener.com
Exclusive-Activist investor Ananym Capital pushes for changes at Henry Schein, sources say By Reuters - Investing.com
Exclusive: Activist investor Ananym Capital pushes for changes at Henry Schein, sources say - Reuters.com
Dental company stocks jump amid RFK Jr.'s health claims about fluoride - CBS News
A dental stock rises as RFK Jr. threatens to remove fluoride from America's water - Quartz
U.S. STOCKS Henry Schein Inc, Palantir Technologies, Uber Technologies - XM
Ananym urges Henry Schein to cut spending, sell unit, Reuters reports - TipRanks
Exclusive-Activist Investor Ananym Capital Pushes for Changes at Henry Schein, Sources Say - U.S News & World Report Money
Henry Schein gains amid activist speculation after 13F filing, conference appearance - Seeking Alpha
Dental supply stock rallies on theory RFK's anti-fluoride stance will prompt more dentist visits - MSN
Dental supply stock surges on RFK's anti-fluoride stance, activist involvement - CNBC
Clarkston Capital Partners LLC Purchases 71,560 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 33,053 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Curi RMB Capital LLC Cuts Stock Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
UBS: Henry Schein, Inc. (NASDAQ:HSIC) Is A Bottom-Ranked Quant Stock - Insider Monkey
Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by KBC Group NV - MarketBeat
First Week of July 2025 Options Trading For Henry Schein (HSIC) - Nasdaq
Henry Schein Inc. stock underperforms Thursday when compared to competitors - MarketWatch
ING Groep NV Takes $63.23 Million Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Al Gore's Firm Reduces Stake in Henry Schein Inc - GuruFocus.com
Henry Schein, Inc. (NASDAQ:HSIC) Shares Acquired by Speece Thorson Capital Group Inc. - MarketBeat
Henry Schein's (NASDAQ:HSIC) Conservative Accounting Might Explain Soft Earnings - Simply Wall St
Some Investors May Be Willing To Look Past Henry Schein's (NASDAQ:HSIC) Soft Earnings - Yahoo Finance
Amalgamated Bank Has $1.82 Million Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors - Insider Monkey
Artisan Partners Limited Partnership Bolsters Stake in Henry Sch - GuruFocus.com
Henry Schein Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Henry Schein Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
River Global Investors LLP Raises Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein Inc. stock underperforms Friday when compared to competitors - MarketWatch
Tandem Investment Advisors Inc. Sells 27,748 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
FY2025 EPS Estimates for Henry Schein Decreased by Analyst - MarketBeat
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):